NCI Standard Funding Opportunity Announcements
|
|
Current and Recent
Program Announcements |
Current and Recent
Requests for Applications |
Current
and Recent NCI and Trans-NIH Initiatives |
Requests for Proposals
|
Standard Due Dates
|
|
|
| July 08 |
All Faculty |
Federal |
Cancer Epidemiology |
Infrastructure & Methodological Research for Cancer
Epi Cohorts
Support for infrastructure and core functions for existing or new Cancer Epidemiology
Cohorts (CECs).
| Due Dates: |
July 3 - OSR Ι July 8 - Sponsor
|
| Amount &
Project Period: |
Budget not limited for 5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda Nolan,
x6071 |
| FOA Link: |
PAR-14-160 |
|
NEW |
| July 9 (Concept) |
All Ranks |
Non-federal |
HIV |
Implementation Science Research
Evaluating innovative service delivery
models and community partnerships focused on the HIV treatment
cascade for gay men, other men who have sex with men, and
transgender individuals (GMT) in low- and middle-income
countries.
| Due Dates: |
Jul 09 (Concept Paper) Ι Invited:
Aug 22 (OSR) Ι Aug 26
(Sponsor) |
| Amount & Project Period: |
$300,000/year (Total) - 3 years |
| Eligibility: |
All Ranks - Must include balanced
partnership(s) between the research organization and at least one
community-based organization (CBO) or clinic serving GMT populations in
a low- or middle-income country. CBO partner organizations must be led
and largely staffed by GMT individuals. |
| Contact: |
Linda Nolan (x6071) |
| RFA Link: |
Implementation Science Research |
|
 |
| July 10 (Pre-app.) |
All Ranks -
see below |
Federal |
Neurofibromatosis |
Neurofibromatosis Research Program (NFRP)
New Investigator Award
Supports development of independent investigators and/or transition
of established investigators into a career in NF research. Experience
in NF research not required. Preliminary or published data required
Clinical trials not allowed.
| Due Dates (All
NFRP opps except as noted below): |
July 10
(Pre-app.) Ι
July 22 (OSR) Ι July 24 (Sponsor)
|
| Contact: |
Linda Nolan
(x6071) |
| Amount & Project Period: |
$400,000 (Direct Costs) - 4 years
|
| Eligibility: |
Independent investigator at or
below Asst. Member or equiv. |
| Contact: |
Linda Nolan
(x6071) |
| PA Link: |
W81XWH-14-NFRP-NIA
|
Investigator-initiated Research Award
Supports highly rigorous, high-impact research with potential to
make an important contribution to NF research and/or patient care.
Preliminary or published data required. Optional Qualified Collaborator:
Applications that include a Qualified Collaborator meeting criteria
identified in the Program Announcement may apply for a higher level
of funding. Clinical trials not allowed.
| Amount &
Project Period: |
$525,000 (Direct Costs)
$575,000 if incl. Optional Qualified Collaborator
- 3 years
|
| Eligibility: |
At or above Asst. Member
|
| PA Link: |
W81XWH-14-NFRP-IIRA |
Exploration Hypothesis Development Award
Supports initial exploration of innovative, high-risk, high-gain
concepts in NF research laying groundwork for future avenues of
investigation. Preliminary or published data encouraged but not
required. Clinical trials not allowed.
| Amount & Project Period: |
$100,000 (Direct Costs) - 2 years
|
| Eligibility: |
All Ranks |
| PA Link: |
W81XWH-14-NFRP-EHDA |
Clinical Trial Award
The CTA funds Phase 0, I, or II clinical trials relevant to NF and/or
schwannomatosis. Combinations of phases are permitted. Scientific
rationale and/or preliminary data are required for pilot trials
and for Phase I, II trials.
| Amount & Project Period: |
$900,000 (Direct Costs) - 4 years
|
| Eligibility: |
At or above Asst.member |
| PA Link: |
W81XWH-14-NFRP-CTA |
|
NEW |
| July 11 |
Jr. faculty |
Non-federal |
Pain Research |
Future Leaders in Pain Research Grant Program
Encourages research in pain that will add to existing body of knowledge, and allow investigators to develop pilot data to aid in securing additional major grant funding.
|
 |
| July 15 |
All Faculty Ranks |
Internal Funding |
Clinical Trials |
Moffitt Clinical Trial Funding Opportunity - Cycle II
Emphasis on increasing minority accrual and utilization of Total
Cancer Care. Funding will be awarded to a proposal for an
investigator-initiated phase 0, I, or II therapeutic or supportive
care clinical trial that addresses an underrepresented population
and is likely to lead to increased minority subject accrual.
| Due Dates: |
July 15 (as a pdf file to
Maureen Ahearn
(x8824) |
| Amount &
Project Period: |
$100,000 for the clinical trial
(including trial coordination, data management, non-billable
lab tests, etc.) and up to $50,000 for correlative science
costs (including shared resources, research lab supplies
and tech support). |
| Eligibility: |
All Faculty Ranks |
| Contact: |
Maureen Ahearn
(x8824) |
| RFA Link: |
RFP Clinical Trial Funding Opportunity
|
|
NEW |
| July 17 (Pre-app) |
Postdocs/Jr Faculty |
Non-federal |
Breast |
Susan G. Komen for the Cure Foundation - 2014-2015 Requests
for Applications
As more is learned about the factors that make cancer cells grow
and spread, more is invested in the translation of this
knowledge into treatment, early detection and prevention.
|
|
|
Career Catalyst Research Grants (CCR)
|
|
|
Hypothesis-driven research projects having significant potential to advance understanding of breast cancer and lead to reductions in breast cancer incidence and/or mortality in 2 Research Focus Areas: Basic/Translational and Clinical.
| Amount & Project Period: |
$150,000/year - 3 years |
| Eligibility: |
Terminal Degree req’d. Must have faculty appt.
or formal offer at time of full application or
< 6 years in faculty
appt
Not currently a PI on an existing R01
Not required to be a U.S. citizen or resident |
| RFA Link: |
Career Catalyst Research Grants (CCR) |
|
|
|
Graduate Training in Disparities Research (GTDR)
|
|
|
To establish and/or sustain a training program for a minimum of
three graduate students who are seeking careers dedicated to
understanding and eliminating disparities in breast cancer
outcomes across population groups
|
|
Postdoctoral Fellowship Grants
|
|
|
Basic/Translational Research:
Both basic (Ph.D.) or clinical (M.D.) fellows proposing research
projects that are laboratory- or field- based and do not meet
Komen's definition of clinical research.
Clinical Research:
Clinical, patient-oriented research projects that involve direct
interactions with human subjects/patients, including studies
such as therapeutic interventions or clinical trials.
| Amount & Project Period: |
$60,000/year - 3 years |
| Eligibility: |
MD, PhD, DrPH, DO, req'd.
May not hold faculty appointment
Is not required to be a U.S. citizen or resident |
| RFA Link: |
Postdoctoral Fellowship Grants |
|
|
|
| July 23 (Pre-app.) |
See Below |
Federal |
Biospecimen Resource Site |
Prostate Cancer Research Program
Prostate Cancer Biospecimen
Resource Site Award
Support the expansion of the PCBN by adding Resource Sites that will enhance the
biorepository's utility to prostate cancer researchers through the
provision of biospecimens that are unique and/or in limited supply.
| Due Dates: |
July 23 (Pre-app) Ι Invited: Oct 27 (OSR) Ι Oct 29 (Sponsor) |
| Contact: |
Linda Nolan
(X6071) |
| Amount & Project Period: |
$200,000/year (Direct
Costs) - 2 years |
| Eligibility: |
Assistant Member or above |
| PA Link: |
W81XWH-14-PCRP-PCBRSA |
|
|
Laboratory - Clinical Transition Award
Supports product-driven preclinical studies of promising lead agents
or medical devices that have the potential to revolutionize prostate
cancer clinical care.
| Amount & Project Period: |
$500,000/year (Direct Costs) -
3 years |
| Eligibility: |
Assistant Member or above |
| PA Link: |
W81XWH-14-PCRP-LCTA
|
|
|
Dr. Barbara Terry-Koroma Health Disparity Research Award
Supports new ideas based on innovative concepts or methodologies
for health disparity research with the potential to make an important
contribution toward eliminating death from prostate cancer and enhancing
the well-being of men impacted by the disease. Applicants for this
award must explicitly state how the proposed research is related
to an area of prostate cancer health disparity.
| Due Dates: |
July 23 (Pre-app) Ι Invited: Sept 22 (OSR)
Ι Sept 24
(Sponsor) |
| Amount &
Project Period: |
$350,000 (Direct Costs) - 3 years
(New & Established Investigators
$600,000 (Direct Costs - 3 years (If using Qualified Collaborator
Option)
Additional $92,500 (if using Nested Health Disparity Traineeship
Option for pre-doctoral trainee)
Additional $115,000 (if using Nested Health Disparity Traineeship
Option for postdoctoral trainee) |
| Eligibility: |
Assistant Member or above |
| PA Link: |
W81XWH-14-PCRP-HDRA
|
|
|
Clinical Exploration Award
Supports clinical trials encompassing Phase 0, Phase I, or pilot
Phase II for drugs or drug combinations, Class II or III for devices,
or other types of trials conducting early clinical testing of innovative
approaches for prostate cancer. Also supports innovative,
hypothesis-based, correlative studies that derive from ongoing or
completed clinical trials supported by other funding sources.
| Amount &
Project Period: |
$450,000 (Direct
Costs) - 5 years |
| Eligibility: |
Assistant Member or above. |
| PA Link: |
W81XWH-14-PCRP-CEA |
|
NEW |
| July 23 (Abstracts) |
Postdocs/Jr.Faculty |
Non-federal |
Gynecologic |
2014-2015 Research Grants & Awards
Supports research and training related to gynecologic cancers. Application should be for ovarian cancer research, endometrial cancer research or gynecologic cancer research.
|
 |
| July 28 |
Postdocs |
Non-Federal |
Career Development |
Stand Up To Cancer-Cancer Research UK Translational Research
Fellowship
Translational research addressing critical problems in cancers with
potential to deliver patient benefit.
| Due Dates: |
July 24 - (OSR) Ι July 28 - (Sponsor) |
| Amount &
Project Period: |
$315,000 total costs for 4 years |
| Eligibility: |
Open to US and UK-based individuals
holding a PhD and/or a US medical degree and have less than
2 years of postdoctoral or clinical research experience.
Must identify 1 qualified US host laboratory and mentor,
and 1 qualified UK host laboratory and mentor. Work must
be performed in 2 phases: 1 in the United States and 1 in
the United Kingdom. |
| Contact: |
Linda Nolan, x6071 |
| Links: |
SU2C Funding Opportunities - AACR
Cancer Research UK Program
Guidelines |
|
|
|
| July 28 |
Sr.
Faculty |
Federal |
Big Science Training |
Pre-doctoral Training in Biomedical Big Data Science
This pre-doctoral training initiative:
1. Requires trainees to work effectively at the intersection of
computer science/informatics, statistics/mathematics, and biomedical
science;
2. Expects active participation of training faculty from all 3 of
these scientific disciplines working collaboratively as co-mentors
of trainees in Big Data Science; and
3. Develops skills required to participate in a team approach to
solving data-intensive biomedical problems.
| Due Dates: |
July 24 (OSR) Ι July 28 (Sponsor)
|
| Amount &
Project Period: |
Approximately $350,000 total costs
over 5 years |
| Eligibility: |
Established Investigators in areas
relevant to biomedical Big Science Data. |
| Contact: |
Linda Nolan,
x6071 |
| RFA Link: |
RFA-HG-14-004 |
|
|
|
| July 28 (LOI) |
All Ranks |
Federal |
Health Disparities |
Basic and Applied Biomedical Research on Minority Health and
Health Disparities
Basic and applied research on fundamental biological mechanisms
involved in disease conditions that disproportionately affect health
disparity populations and therapies, or interventions that can directly
or demonstrably contribute to reducing or eliminating health disparities.
| Due Dates: |
July 28 (LOI) Ι
August 26 (OSR) Ι August 28 (Sponsor) |
| Amount & Project Period: |
$250,000 (Direct Costs) - 5 years
|
| Eligibility: |
All Ranks |
| Contact: |
Linda Nolan
(X6071) |
| RFA Link: |
RFA-MD-14-005 |
|
|
| July 29 (Pre-app) |
All Ranks |
Federal |
Lung |
Lung Cancer Research Program
Concept Award
The Concept Award supports highly innovative, untested, potentially
groundbreaking concepts in lung cancer w/emphasis on innovation.
Projects involving human subjects or human biological substances
must be exempt or eligible for expedited review. Clinical trials
not allowed. Preliminary data discouraged.
| Due Dates: |
July 29 (Pre-app) Ι
August 08 (OSR) Ι August 12 (Sponsor) |
| Amount & Project Period: |
$100,000 (Direct Costs) -1 year
|
| Eligibility: |
All Ranks |
| Contact: |
Linda Nolan
(x6071) |
| RFA Link: |
W81XWH-14-LCRP-CA
|
|
 |
| July 31 |
Postdocs &
Faculty |
Non-Federal |
Cutaneous Lymphoma |
2014 CLARIONS Award Program -
Curing Cutaneous Lymphoma by Advancing Research, Innovation
and Offering New Solutions
Innovative research in all areas of cutaneous lymphomas with particular interest
in etiology and risk factors of cutaneous lymphomas, measures of
disease impact on effected individuals and populations, translating
discoveries into diagnostic and therapeutic advances, optimizing
therapies and improving quality of life for individuals with
cutaneous lymphomas.
| Due Dates: |
July 29 (OSR)
Ι July 31 (Sponsor) |
| Amount &
Project Period: |
$25,000 for 1 year |
| Eligibility: |
Investigators at all levels, from
clinical and postdoctoral fellows to established investigators,
are eligible to receive awards. Medical students and graduate
students are not eligible. |
| Contact: |
Linda Nolan,
x6071 |
| Links: |
Research Awards Program
CLARIONS Application Manual
Grant Application |
|
 |
| August 1 |
Postdocs/Fellows |
Non-federal |
CDA/Neurology |
Medical Education Research Training Fellowship
Priority given for plans evaluating educational outcomes impacting
learning and medical practice change, population health outcomes, &
patient quality or safety outcomes Intervention population may be
medical students, residents, practicing physicians (i.e., CME),
or inter-professional health care teams.
| Due Dates: |
July 30 (OSR)
Ι August 01 (Sponsor)
|
| Amount & Project Period: |
$65,000 - 1 year
|
| Eligibility: |
Must be an AAN member (Active or
Junior) embarking on a career in medical education research
who has completed a neurology, child neurology, or neuro-developmental
disabilities residency or neurology fellowship w/in the
past 5 years.
|
| Contact: |
Linda Nolan
(x6071)
|
| Links: |
Application Guidelines
AAN Overview
|
|
NEW |
| August 1 |
Postdocs & Jr Faculty |
Non-federal |
HIV Malignancies |
Young Investigator Pilot Award
To support innovative ideas for clinical and/or behavioral-epidemiological HIV-related research that utilizes ACSR's annotated biospecimens.
| Due Dates: |
July 30 (OSR) Ι August 01 (Sponsor) |
| Amount & Project Period: |
$20,000 (Direct Costs only) |
| Eligibility: |
Hold a faculty appointment or be mentored by a
faculty member
Required to utilize specimens from the ACSR |
| Contact: |
Linda
Nolan (X6071) |
| RFA Link: |
ACSR Young Investigator Pilot Award |
|
|
|
| August 3 |
All Faculty |
Federal |
Mouse Models |
Collaborative Research Projects to Enhance Applicability of
Mouse Models for Translational Research (Collaborative R01)
Applications sought from multi-disciplinary teams to expand, improve,
or transform the utility of mouse cancer and tumor models for translational
research.
For a linked set of collaborative R01s, each site has its own Program
Director(s)/Principal Investigator(s), and the program provides
a mechanism for cross-site coordination and communication.
| Due Dates: |
July 31 (OSR)
Ι August 03 (Sponsor)
|
| Amount & Project Period: |
$450,000/year (Direct Costs) -
3 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda Nolan
(X6071) |
| FOA Link: |
PAR-14-240 |
|
|
|
| August 3 |
All Ranks |
Federal |
Mouse Models |
Research Projects to Enhance Applicability of Mouse Models
for Translational Research
Scope: Overcoming limitations
of mouse and human-in-mouse oncology models, defining a new
translational use of models or mouse genetics for unmet needs, advancing
standard practices for modeling human cancers and tumors in mice,
and for validating and credentialing models, or develop widely applicable
tool strains or resources that enable cross-species comparisons.
| Due Dates: |
July 31 (OSR)
Ι August 03 (Sponsor)
|
| Amount & Project Period: |
$450,000/year (Direct Costs ) -
3 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda Nolan
(x6071) |
| FOA Link: |
PAR-14-241 |
|
|
| August 07 |
All Faculty |
Federal |
Mouse Models |
Oncology Models Forum
Establish and maintain an "Oncology Models Forum" Focus is anticipated
to be on effective, reliable use of mice, mouse models, and human-in-mouse
models in translational cancer research, and other mouse modeling
needs that the scientific community identifies.
| Due Dates: |
July 02 (LOI)
Ι
August 05 (OSR) Ι August 07 (Sponsor)
|
| Amount & Project Period: |
$750,000/year (Direct Costs) -
5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda Nolan
(X6071) |
| FOA Link: |
PAR-14-239 |
|
NEW |
August 1 (LOI)
October 15 |
Clinical Faculty |
Non-federal |
Unrestricted |
Clinical Research Professor
Awarded to outstanding mid-career investigators who have made
seminal contributions that have changed the direction of
clinical, psychosocial, behavioral, health policy or
epidemiologic cancer research.
|
NEW |
| August 8 |
All Ranks |
Non-federal |
Mesothelioma |
Grants for Mesothelioma Research
Encouraged projects include strategies for early detection;
definition of targetable differences between normal & transformed mesothelium and
development of novel strategies for treatment taking advantage of these targets;
determination of clinical/molecular determinants for prognosis;
and therapeutic interventions.
|
 |
| August 13 |
Postdocs/Jr Faculty |
Non-federal |
Lung Cancer |
Uniting Against Lung Cancer (UALC) - Legacy Program
Seed money for promising and potentially transformative new projects.
Interdisciplinary collaborations strongly encouraged. Does not require
large amounts of preliminary data, but must have a clear hypothesis
and research plan.
| Due Dates: |
August 11 (OSR)
Ι August 13 (Sponsor)
|
| Amount & Project Period: |
$50,000/year (Incl. 10% F&A)
- 2 years
|
| Eligibility: |
Hold a faculty appointment or be
mentored by a faculty member
|
| Contact: |
Linda Nolan
(x6071)
|
| Links: |
Legacy Program (Guidelines)
Uniting Against Lung Cancer (Funding Opps. Page) |
|
|
|
| August 11 |
Jr Faculty |
Internal Funding |
Career Development |
Moffitt Medical Group (MMG)
Junior Faculty Team Research Award Cycle I
Promotes exploration of
innovative ideas and establishment of new collaborations.
MMG
Junior Faculty Team Research Award may be awarded to
investigators working with animal models, or to
investigators using human tissue, fluid or blood samples for
pre-clinical studies.
| Due Dates: |
August 11 (Single pdf file to Kim Murphy by 4:00pm) |
| Amount & Project Period: |
$20,000 to $50,000 - 1 year |
| Eligibility: |
MD or PhD, and member of Moffitt Medical Group (MMG).
Must have a track record of productivity.
Those new to cancer research will receive priority. |
| Contact: |
Kim
Murphy (x1432) |
| RFA Link: |
MMG Jr. Faculty Team Research Guidelines
| Application |
|
|
| August 15 |
Postdoc/Fellows |
Non-federal |
Career Development |
Damon Runyon Fellowship Award
Supports all theoretical and experimental research relevant to the
study of cancer and the search for cancer causes, mechanisms, therapies and prevention.
| Due Dates: |
August 13 (OSR)
Ι
August 15 (Sponsor)
|
| Amount & Project Period: |
3-year period
Level 1: Stipend: $50,000/yr. Allowance: $2,000/yr
Level 2: Stipend: $60,000/yr. Allowance: $2,000/yr.
|
| Eligibility: |
Level 1 Funding: Basic and physician-scientist
– degree received
Less than 1 year prior to the Fellowship Award Committee (FAC) meeting when application is considered, and not have been in Sponsor's lab
more than 1 year prior to meeting.
Level 2 Funding: Physician-scientist applicant - (MD, MD/PhD, DDS, DVM or equiv.) must have completed residency
& clinical training and be board-eligible in U.S. at award.
Postdoctoral fellows, clinical fellows and clinical instructors are eligible. Foreign candidates may apply to do research only in U.S.
|
| Contact: |
Linda Nolan (X6071)
|
| Link: |
Fellowship Application Guidelines
|
|
|
NEW
|
| August 15 |
All Ranks |
Federal |
Smoking Cessation |
Exploratory Studies of Smoking Cessation Interventions for
People with Schizophrenia
Applications to generate and conduct preliminary tests of targeted smoking cessation treatments for individuals with schizophrenia. Applications that focus on early-stage,
treatment generation and pilot clinical trials that are consistent with an experimental therapeutic approach are encouraged.
| Due Dates: |
August 13 (OSR) Ι August
15 (Sponsor) |
| Amount & Project Period: |
R21: $275,000/year (Direct Costs) - 2 years
R33: $450,000 (Direct Cost Total)
- 3
years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (X6071) |
| FOA Link: |
PAR-14-230 |
|
|
NEW
|
| August 15 |
All Ranks |
Federal |
Smoking Cessation |
Exploratory Studies of Smoking Cessation Interventions for
People with Schizophrenia
Type I will conduct exploratory testing of novel, targeted
treatments for smoking cessation for individuals with
schizophrenia. Type II will conduct exploratory testing of
targeted implementation strategies of existing efficacious
treatments at the service-delivery system level.
| Due Dates: |
August 13 (OSR) Ι August
15 (Sponsor) |
| Amount & Project Period: |
$450,000 (Direct Cost Total)
- 3
years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-14-231 |
|
|
|
August 1 (Pre-app)
|
Jr Faculty |
Federal |
Breast Cancer |
Breast Cancer Research Program (BCRP)
Era of Hope Scholar
Award
Central feature of the award is innovative contribution of Principal
Investigator (PI) toward ending breast cancer. PI should
articulate a vision challenging current dogma and demonstrating
ability to look beyond tradition and convention.
|
Due Dates: |
August 1 (Pre-app) Ι August 13 (OSR)
Ι
August 15 (Sponsor)
|
| Amount & Project Period: |
$2,500,000 direct costs for 5 years.
|
| Eligibility: |
Jr. Faculty: Independent investigator within 6 years
of last training position.
|
| Contact: |
Linda Nolan, x6071
|
| PA Link: |
W81XWH-14-BCRP-EOHS
|
|
|
|
August 11 (LOI)
|
All Faculty |
Federal |
Radiation Dosing |
Decreasing Patient Radiation Dose from CT
Imaging: Achieving Sub-mSv Studies
Research leading to reduction of patient radiation exposure from a routine
CT scan to exposures <1 mSv.
|
Due Dates: |
August 11 (LOI)
Ι Sept 07 (OSR)
Ι Sept 11 (Sponsor) |
| Amount & Project Period: |
Unlimited budget - 4 years
|
| Eligibility: |
All Faculty
|
| Contact: |
Linda
Nolan, (x6071)
|
| FOA Link: |
PAR-12-206
|
|
 |
| August 15 |
All Ranks |
Non-Federal |
Pancreatic Cancer |
Hershberg Foundation for Pancreatic Cancer Research Seed Grants
To provide start-up funding to test innovative ideas for improving diagnosis and to develop new treatment modalities
in pancreatic cancer; obtain preliminary data required for additional funding
impact on the understanding of pancreatic cancer cell biology, biochemistry, physiology, morphology and response to therapy
and to establish collaborations within the field.
| Due Dates: |
August 13 (OSR)
Ι
August 15 (Sponsor)
|
| Amount & Project Period: |
$50,000 - 1 year (Renewable)
|
| Eligibility: |
All Ranks
|
| Contact: |
Linda
Nolan, x6071
|
| RFA Link: |
Seed Grants
|
|
|
NEW
|
| August 17 (LOI) |
All Faculty |
Federal |
Screen-detected Lesions |
Molecular and Cellular Characterization of Screen-Detected
Lesions - Coordinating Center and Data Management Group
Applications for a Coordination and Data Management Group (CDMG)
to conduct biological analysis of screen-detected,
interval-detected, and symptom-detected cancers.
Responsibilities will be: 1) coordination of consortium-wide
meetings and conferences, and collaborative activities; 2)
statistical support and computational analysis; and 3) data
management and protocol development for the biorepository.
| Due Dates: |
Aug 17 (LOI)
Ι September 15 (OSR) Ι September 17 (Sponsor) |
| Amount & Project Period: |
Not to exceed $300,000 (Direct costs) - 3 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda Nolan (x6071) |
| RFA Link: |
RFA-CA-14-011 |
|
|
|
| August 27 (Pre-app.) |
Postdocs |
Federal |
Career Development |
Prostate Cancer Research Program
Postdoctoral Training Award
Supports prostate cancer research training opportunities for recent doctoral graduates.
| Due Dates: |
August 27 (Pre-app)
Ι
Sept 08 (OSR) Ι Sept 10 (Sponsor)
|
| Contact: |
Linda Nolan (x6071) |
| Amount & Project Period: |
$57,500/year (Direct Costs) - 2 years
|
| Eligibility: |
Postdocs
|
| PA Link: |
W81XWH-14-PCRP-PTA
|
|
|
|
Physician Research Training Award
Supports a mentored training experience to prepare physicians with clinical duties and/or responsibilities for productive careers in prostate cancer research.
Emphasizes equally the quality of both the research and the training proposed.
| Amount & Project Period: |
$130,000/year (Direct Costs) - 4 years
|
| Eligibility: |
Must be a physician with clinical duties in the last year as resident/fellow or within 3 years of Jr
Faculty appointment.
|
|
PA Link: |
W81XWH-14-PCRP-PRTA
|
|
 |
| August 29 |
Established Faculty |
Non-federal |
Gastric Cancer |
R. Robert & Sally Funderburg Research Award in Gastric Cancer
Novel approaches in gastric cancer research, including: gastric mucosal cell biology;
regeneration and regulation of cell growth; inflammation as precancerous lesions; genetics of gastric carcinoma;
oncogenes in gastric epithelial malignancies; epidemiology of gastric cancer; etiology of gastric epithelial
malignancies; or clinical research in diagnosis or treatment of gastric carcinoma.
| Due Dates: |
August 27 (OSR) Ι
August 29 (Sponsor)
|
| Amount & Project Period: |
$50,000/year - 2 years |
| Eligibility: |
Established Investigator in Gastric Biology
AGA membership required at time of submission |
| Contact: |
Linda Nolan, x6071
|
| RFA Link: |
Research Award in Gastric Cancer |
|
NEW |
| September 01 |
Jr. faculty |
Non-federal |
See Programs
Below |
PhRMA Foundation
| Due Dates: |
August 28 (OSR) Ι September 01 (Sponsor) |
| Contact: |
Linda
Nolan, x6071 |
| Primary Link: |
2015 Awards
|
Pre-doctoral fellowships: |
$20,000/year - 2 years |
Postdoctoral Fellowships: |
$40,000 stipend only/year - 2 years |
Research Starter Grants: |
$100,000 - 1 year |
Center for Adherence Improvement
Support for career development activities of individuals prepared to engage in research that is aimed at improving medication adherence. Relevant research goals include development or evaluation of policies, interventions, or tools potentially successful in improving medication adherence.
|
Pre-doctoral Fellowship |
Full-time, advanced, in-residence PhD candidates in the field of pharmaceutics. Must hold a BS, MS, or PharmD in pharmacy or a related area such as chemistry or biology
|
|
Post Doctoral Fellowships |
Must hold a PhD degree in pharmaceutics or a related discipline from
an accredited U.S. university or expect to receive such a degree before
activation of fellowship
|
|
Research Starter Grants |
Must be in a tenure track position 3 or less years w/a rank of instructor
or asst. professor and doctoral level investigators w/equivalent positions Proposed research may not be subsidized to any significant degree by a competitive extramural grant. US citizen/permanent resident only.
|
|
|
|
Informatics ProgramPromotes development and use of informatics in an integrative approach towards understanding human biological and disease processes. Preference is for research that combines novel computational methods together with experimental validation.
Proposals must contain innovative informatics components, and not solely apply bioinformatic methodologies to experimental data analysis.
|
Predoctoral Fellowship -
2 applications per institution |
Full-time, advanced, in-residence PhD candidates in the fields of informatics
|
|
Postdoctoral Fellowship |
Must either hold a PhD degree in an area logically or functionally related to the proposed postdoctoral activities, or expect to receive the PhD before activation of award. US citizens and Permanent residents
|
|
Research Starter Grants |
Jr. Faculty - Tenure track |
|
|
|
Pharmacology/Toxicology ProgramResearch that integrates information on molecular or cellular mechanisms of action with information on the effects of an agent observed in an intact organism, either in experimental animal or clinical studies or both. Priority is given for research attempting to integrate information on the mechanism of action of a drug or chemical at the molecular or cellular level with the drug effect observed in a human or laboratory animal.
| Due Date: |
August 29 (OSR) Ι
September 01 (Sponsor) |
|
Pre Doctoral Fellowships - 1
application per institution |
Full-time, advanced, in-residence PhD candidates in the fields of pharmacology or toxicology |
|
Post Doctoral Fellowships |
Must either hold a PhD degree in an area logically or functionally related to the proposed activities or expect to receive the PhD before activation of award. |
|
Research Starter Grants |
Academic rank of instructor or assistant professor and doctoral level investigators w/equivalent positions.
Proposed research may not be subsidized by a competitive extramural grant. |
|
|
|
Pharmaceutics
Research that integrates information on molecular or cellular
mechanisms of action with information on the effects of an agent
observed in an intact organism, either in experimental animal or
clinical studies or both. Priority given for research attempting
to integrate information on the mechanism of action of a drug or
chemical at the molecular or cellular level with the drug effect
observed in a human or laboratory animal.
|
Pre Doctoral Fellowships |
Full-time, advanced, in-residence PhD candidates in the field of
pharmaceutics. Must hold a BS, MS, or PharmD in pharmacy or a
related area such as chemistry or biology
|
|
Post Doctoral Fellowships |
Must hold a PhD degree in pharmaceutics or a related discipline from
an accredited US university or expect to receive such a degree before
activation of fellowship
|
|
Research Starter Grants |
Must be in a tenure track position <3
years w/rank of instructor or asst. professor & doctoral level
investigators w/equivalent positions Proposed research may not be
subsidized to any significant degree by a competitive extramural grant. |
|
NEW |
| September 3 |
All Faculty |
Non-federal |
Team Science |
AACR Team Science Award
The research to be recognized should reflect work towards a
specific scientific goal that otherwise would not be realized by
any single component of the team.
| Due Date |
September 01 (OSR) Ι September
03 (Sponsor) |
| Amount & Project Period: |
$50,000 |
| Eligibility: |
Team is comprised of independent faculty-level researchers who may be working w/in same institution or at several institutions |
| Contact: |
Linda
Nolan (x6071) |
| Link: |
2015 AACR Team
Science Award |
|
NEW
|
| September 3 |
Postdocs/Jr. faculty |
Non-federal |
Lymphoma |
Lymphoma Research Foundation
Clinical Investigator Career Development Award RFP
Supports physician investigators who will contribute to the
development of new lymphoma therapies and diagnostic tools.
| Amount & Project Period: |
$225,000 - 3 years |
| Eligibility: |
MD with less than 5 years' experience after postdoc
training |
Postdoctoral Fellowship
Grant RFP
Laboratory or clinic based research w/results & conclusions
clearly relevant to the treatment, diagnosis or prevention of
Hodgkin and/or non-Hodgkin lymphoma. Areas of research may
include, but are not limited to, etiology, immunology, genetics,
therapies and transplantation.
| Amount & Project Period: |
$105,000 - 2 years |
| Eligibility: |
Completed 2 years of postdoc training or have <
2 years as instructor/assistant member at award and spend 80% time on
research. |
Lymphoma Clinical
Research Mentoring Program RFP
A Training Program with a focus on Clinical Research in the
field of non-Hodgkin and Hodgkin lymphoma. Projects must be
focused on a proposed hypothesis-driven clinical research
project in lymphoma.
| Amount & Project Period: |
$10,000 - 2 years |
| Eligibility: |
Jr. Faculty in first 3 years or trainees in at
least 2nd year of one of the ACGME accredited fellowship programs:
Hematology/Oncology, Hematology, Medical Oncology, Radiation Oncology,
or Hematopathology |
Adolescent/Young Adult (AYA) Cooperative Group Correlative
Studies
For correlative clinical/translational studies in
adolescent/young adult (AYA) lymphomas. Applications must be an
adjunct to a major National Cancer Institute (NCI) cooperative
group research project in lymphoma. Projects should also relate
to work in the clinical setting and/or involve primary lymphoma
patient samples
|
|
NEW
|
| September 07 |
All Ranks |
Federal |
HIV |
Multidisciplinary Studies of HIV and Viral Hepatitis
Co-Infection
To increase understanding of a) the pathogenic interactions
between HIV and hepatitis viruses, b) co-morbidities associated
with HIV/hepatitis virus co-infection, and c) the effectiveness
of interferon-free direct-acting antiviral drug regimens to
treat HIV/HCV co-infection.
| Due Dates: |
Standard AIDS dates Ι Sept 05 (OSR) Ι Sept 07 (Sponsor) |
| Amount & Project Period: |
Budget not limited - 5 years (R01)
$275,000 (Direct Costs) - 2 years (R21) |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Links: |
PAR-14-255 (R01) |
PAR-14-254 (R21) |
|
NEW |
| September 15 |
All Ranks |
Non-federal |
Desmoid Tumors |
Desmoid Tumor Research Foundation
| Due Dates: |
September 11 (OSR) Ι September 15 (Sponsor) |
| Contact: |
Shaina Sine (x3658) |
2014 New Investigator Grants
Funds early stage research to explore new approaches to
advancing current scientific knowledge about desmoid tumors.
Seeks young investigators new to desmoid tumor research and in
need of seed funding to gather preliminary data
| Amount & Project Period: |
$30,000 (Total) - 1 year |
| Eligibility: |
MD, PhD, or equivalent degree at or below level of Associate Professor |
| RFA Link: |
2104
New Investigator RFA |
2014 Research Grant
Funds research to advance current scientific knowledge about
desmoid tumors using cutting-edge science and creative clinical
applications, in addition to novel approaches addressing
potential leads based on prior research
| Amount & Project Period: |
$65,000/year - 1 year |
| Eligibility: |
MD, PhD, or equivalent degree |
| RFA Link: |
2104 Research Grant RFA |
|
NEW |
| September 15 |
Principal Investigators |
Non-federal |
All Areas |
The American Society for Pharmacology and Experimental
Therapeutics - The David Lehr Award
Supports proposals for investigators seeking "bridge" funds to enhance a
grant application for competitive renewal, additional funds for
a research project supported by a "no cost extension" to enhance a resubmission, or funds to acquire preliminary data
in support of a new grant submission.
| Due Dates: |
September 12 (OSR) Ι September 15 (Sponsor) |
| Amount & Project Period: |
$50,000/year - 2 years |
| Eligibility: |
Investigators in need of bridge funding (see
above) Membership in ASPET required |
| Contact: |
Linda
Nolan (X6071) |
| RFA Link: |
ASPET
The David Lehr Award
(Guidelines) |
|
 |
|
September 15 |
Postdocs |
Non-federal |
Career Development |
Sloan Research Fellowships
To stimulate fundamental research by early-career scientists and scholars of outstanding promise
A program designed to stimulate fundamental research by early career scientists and scholars of outstanding promise.
| Due Dates: |
September 11 (OSR) Ι September 15 (Sponsor)
|
| Amount & Project Period: |
$50,000 - 2 years
|
| Eligibility: |
Candidates must hold a tenure track position at a degree-granting institution
that includes a yearly teaching requirement. They must hold a PhD,
awarded on or after September 2008, in chemistry, computational or evolutionary molecular biology, computer science, economics, mathematics, neuroscience, ocean sciences, physics, or a related field. |
| Contact: |
Linda Nolan, (x6071)
|
|
NEW |
| September 18 |
Postdocs |
Non-federal |
Career Trng. |
The Hope Funds for Cancer Research
Postdoctoral Fellowship
Innovative research projects that
challenge traditional paradigms of understanding of causes,
mechanisms, progression, disease markers or risk factors of the
most difficult-to-treat cancers, including pancreatic, lung,
liver, sarcomas, esophageal, brain, gastric, bone and ovarian
cancers; and rare leukemias, lymphomas and MDS.
| Due Date |
September 11 (OSR) Ι September 15 (Sponsor) |
| Amount & Project Period: |
Stipends:
$48,000 (year 01)
$50,000 (year 02)
$52,000 (year 03)
$1,500 (Travel allowance each year)
|
| Eligibility: |
MD, PhD, MD/PhD, DDS, DVM. For foreign-trained
physicians, equivalency will be determined on a case-by-case basis. |
| Contact: |
Linda Nolan (X6071) |
| Links: |
The Postdoctoral Fellowship
Grant Criteria Guidelines |
|
|
| September 30 |
All Faculty |
Non-federal |
Scientific Achievement |
National Foundation for Cancer Research
(NFCR)
2015 Szent-Gyorgyi Prize
Annual prize, in honor of Albert Szent-Gyorgyi, Nobel Laureate and co-founder of NFCR, awarded to an outstanding researcher whose scientific achievements have
expanded understanding of cancer and whose discoveries have made possible new approaches to preventing, diagnosing, and/or treating cancer.
|
 |
|
October 01 |
Postdocs |
Non-federal |
Immunology Career Trng. |
Irvington Post Doctoral Fellowships
Provides critical financial support
and continued career training in cancer immunology.
| Due Dates: |
September 29 (OSR) Ι October 01 (Sponsor)
|
| Amount & Project Period: |
3 Years:
$50,000 - Year 1
$53,000 - Year 2
$57,000 - Year 3
$1,500/year for research support
|
| Eligibility: |
Must have doctoral degree by date of award activation
and have less than 5 years relevant postdoctoral experience with the exception of MD applicants, who should not include years of residency in this calculation.
|
| Contact: |
Linda
Nolan (X6071)
|
| RFA Link: |
Irvington Post
Doctoral Fellowships
|
|
 |
| October 01 |
All Ranks |
Non-federal |
Career Trng. |
Elsa U. Pardee Foundation - Research Grants
Research directed toward identifying new treatments or cures for cancer,
particularly encouraging applications for a one year period which will
allow establishment of capabilities of new cancer researchers, or new
cancer approaches by established cancer researchers.
|
NEW
|
October 04 (LOI)
|
All Faculty |
Federal |
Population Science |
Bridging the Gap Between Cancer Mechanism and Population Science
Incorporating insights and data from one end of the cancer
research spectrum into the framework of the other, projects
should cross-validate data gathered at different scales, and
explore links between basic biology, population science, and
potential health applications in treatment, prevention,
diagnosis, and/or screening.
| Due Dates: |
October 4 (LOI) Ι November 1
(OSR) Ι November 4 (Sponsor) |
| Amount & Project Period: |
Up to $700,000/year (Direct Cost) - 5 years |
| Eligibility: |
All Faculty |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-13-081 |
|
NEW |
| October 15 |
All Ranks |
Non-federal |
LGBT Health |
Lesbian Health Fund (LHF) of GLMA:
Health Professionals Advancing LGBT Equality
2014 - 2015 Research Grants
Especially important areas:
1. Understanding social, family, and interpersonal influences as sources of stress or support;
2. Eliminating inequalities in health care;
3. Development and testing of interventions addressing mental and
physical health needs of lesbians and other SMW, including:
eating disorders, obesity, cancer risks, and sexually
transmitted infections;
4. Sexual and reproductive health, including family and parenting issues.
|
|
|
| October 15 |
PIs w/eligible grants |
Federal |
Dietary Supplements |
Research on Dietary Supplements
To support research where supplemental funding would investigate the role of dietary
supplements and/or their ingredients in health maintenance and disease
prevention. Parent awards need not be focused on dietary supplements
| Due Dates: |
October 13 (OSR) Ι October 15 (Sponsor)
|
| Amount & Project Period: |
$100,000 (Total Costs) - Project and budget periods must
be w/in currently approved project period for existing parent award
|
| Eligibility: |
All PIs w/eligible awards (see FOA) - For parent awards that include
multiple PDs/PIs, supplement may be requested by any or all of the PDs/PIs (in accordance w/existing leadership plan)
|
| Contact: |
Linda Nolan (X6071)
|
| FOA Link: |
PAR-14-201
|
|
|
NEW
|
| November 04 |
All Ranks |
Federal |
GI Microbial
Carcinogenesis |
Role of the Microflora in the Etiology of Gastro-Intestinal
Cancer
Hypothesis-driven studies that can define and validate
molecular mechanisms determining microbe-induced carcinogenic
outcomes
Collaborative efforts between scientists currently engaged in GI
cancer research with those in scientific disciplines that may
not otherwise apply their expertise to study cancer etiology and
prevention are encouraged
| Due Dates: |
October 31 (OSR) Ι November 04 (Sponsor) |
| Amount & Project Period: |
Budgets not limited - 5 years |
| Eligibility: |
All Ranks |
| Contact: |
Linda
Nolan (x6071) |
| FOA Link: |
PAR-14-242 |
|
NEW
|
| November 20 |
All Faculty |
Federal |
Collaboration with NIH |
Pre-application:
Opportunities for Collaborative Research at the NIH Clinical Center
Support for collaborative translational research projects
aligned with NIH efforts to enhance translation of basic
biological discoveries into clinical applications that improve
health.
| Due Dates: |
November 18 15 (OSR) Ι November 20 (Sponsor) |
| Amount & Project Period: |
This is the pre-application step for the
application process for application to
PAR-13-358 (with a due date in March of 2015). |
| Eligibility: |
All Faculty - application must
include at least 1 intramural scientist as a PD/PI or collaborator, and
at least some of the research must be conducted at the NIH Clinical
Center |
| Contact: |
Linda Nolan (x6071) |
| FOA Link: |
PAR-13-357 |
|
